The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's ...
One month after the FDA’s initial approval, the CDC voted to recommend Pfizer’s RSV vaccine for pregnant people who are ...
Updated COVID-19 vaccines may be getting a little easier for adults to find but they’re still frustratingly scarce for young children. Health officials said Thursday the kid shots have started ...
The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...
The FDA approved the first vaccine for pregnant women to prevent RSV in infants. RSV is a disease that’s common in children.
A panel of advisers recommended the Centers for Disease Control and Prevention add Pfizer Inc.’s RSV vaccine to the list of shots for pregnant people to protect infants ...
Now, for the first time, a vaccine is approved for adults 60 and older. But what is RSV? RSV stands for respiratory syncytial ...
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...
By Stacy M. BrownNNPA Newswire Senior National Correspondent@StacyBrownMedia The U.S. Food and Drug Administration (FDA) ...
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...
